Sanctura XR, a new long-acting formulation of trospium, will soon be another option for treating overactive bladder

Sanctura XR, a new long-acting formulation of trospium, will soon be another option for treating overactive bladder.

It'll compete with the other long-acting antimuscarinics...Ditropan XL and Oxytrol (oxybutynin)...Detrol LA (tolterodine)...Vesicare (solifenacin)...and Enablex (darifenacin).

These drugs seem to be similar in efficacy and cost. The big differences are the frequency of side effects and drug interactions.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote